The interleukin-4 receptor (IL-4R) is emerging as a potential drug target, projected to potentially be worth up to 10 billion USD. In this article, ACROBiosystems discusses why it is such an attractive drug target and what this could entail.
CETP inhibitor class finally dies as Merck abandons anacetrapib pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Rapid deterioration in sense of smell is a strong predictor of both Alzheimer s-related cognitive impairment and loss of brain volume, new research suggests.